학술논문

Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Document Type
Academic Journal
Source
Annals of Oncology. Dec 01, 2017 28(12):2932-2942
Subject
Language
English
ISSN
0923-7534